As we edge toward the third decade of the century, business-as-usual methodologies no longer keep pace with the tides of innovation and unprecedented change.
Only logged in customers who have purchased this product may leave a review.
You may also like
This paper complements PwC’s Project Blue1 and the PwC Megatrends framework2, which examines the forces that are disrupting the role, structure, and competitive environment for financial institutions and the markets and societies in which they operate.
Financial Services Technology 2020 and Beyond$0.00 Pwc
Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Artificial Intelligence in Life Sciences$0.00 LEK
In 2007, medical leaders from across the pharmaceutical industry assembled to develop a common understanding of a ten-year vision for Medical Affairs. With five years now past, it is hardly surprising that significant change has occurred in the world in which the pharmaceutical industry operates, especially given the remarkable economic environment and the continued acceleration of technological change.
Pharma Medical Affairs 2020 and beyond$0.00 McKinsey
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?
Want to join our Community?
- This Week In Consulting: How do Travel & Hospitality cope with the Covid crisis?by Hélène Laffitte on October 28, 2020 at 7:36 am
This Week in Consulting - Curated News on the Consulting Industry published every Wednesday brought to you by Consulting Quest. This week,October 28th ,2020, […]